Track record · closed signal

CareTrust REIT, Inc. (CTRE) — closed signal from March 8, 2026

Partial Published before the outcome was known, scored automatically when the window closed on June 6, 2026.

Predicted vs. what happened

CTRE price · publication thesis → realized outcomesplit-adjusted
$39.94 Published $44.33 Target $37.97 Window close $43.08 Peak
$39.00 – $40.20Entry zone — fair-value band
$39.94Published — price the day we called it
$44.33Target — the price the thesis aimed for
$43.08Peak — highest point inside the window, not a realized return
$37.97Window close — end-of-window price, context only

What happened

Partial

Reached 72% of the predicted growth at its peak, without hitting the target.

Peak price
$43.08
peak on May 14, 2026 — not a realized return
Peak gain
+7.9%
peak, from the publication price
Window close
$37.97
end-of-window price, context only
Days to target
Window
March 8, 2026 – June 6, 2026

The thesis — published March 8, 2026

Predicted growth
+11%
over the measurement window
Target price
$44.33
the price the thesis aimed for
Entry zone
$39.00 – $40.20
the fair-value band we waited for
Price at publication
$39.94
published March 8, 2026
Confidence
82%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

CTRE looks like a reasonable short-term idea because the company is showing better operating results and analysts have raised their numbers. Being added to the S&P MidCap 400 could force some funds to buy the stock. Because it already moved up, it's safer to wait for a small pullback instead of buying at the top.

Primary drivers

  • Improving earnings and upward analyst estimates
  • Index addition should bring automatic buying from funds
  • Growth from buying more healthcare properties keeps revenue visible
  • Calmer price swings suit a short holding period

How it played out

CTRE: thesis partly played out, target missed

Lyra published CTRE on 2026-03-08 at 39.94 as a short-term idea with 11% expected growth. The thesis pointed to improving earnings, upward analyst estimates, possible automatic buying after S&P MidCap 400 addition, growth from buying more healthcare properties, and calmer price swings for a short holding period.

Inside the window, the stock rose, but it did not reach 44.33. Its best print was 43.08 on 2026-05-14, a 7.9% gain. It never got there. By 2026-06-06, CTRE ended at 37.97. The thesis partly played out on the move toward the target, but the published target was missed.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.